ERBB2 and breast cancer: Several oncoproteins or tumor suppressors including HER-2 and p53 have also been found to predict clinical outcome or prognosis of breast cancer, and Twist has already been used as a prognostic marker in cervical cancer[10], bladder and prostate cancers[11] and chronic kidney disease[12].